Mycobacterium tuberculosis with extensive resistance;Résistances de Mycobacterium tuberculosis

Medecine/Sciences

Volumn 23, Issue 2, 2007, Pages 205-209

  Labie, Dominique ^a  

^a INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; AMINOSALICYLIC ACID; BCG VACCINE; CYCLOSERINE; ISONIAZID; QUINOLONE DERIVATIVE; RIFAMPICIN;

BACTERIUM CONTAMINATION; CANCER CHEMOTHERAPY; CONSULTATION; COST BENEFIT ANALYSIS; DRUG EFFICACY; ENVIRONMENTAL FACTOR; ERADICATION THERAPY; HUMAN; MORBIDITY; MORTALITY; PHYSICIAN; PRESCRIPTION; PROPHYLAXIS; PUBLIC HEALTH SERVICE; REVIEW; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 33847121596     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2007232205     Document Type: Review

References (26)

1. e Assemblée de l'Organisation Mondiale de la Santé, 5 mai 2000. Initiative Halte à la tuberculose. Rapport du Directeur général. Geneva : WHO, 2000.
2. Déclaration d'Amsterdam visant à faire barrage à la tuberculose, 24 mars 2000. Amsterdam (Pays-Bas), 2000.
3. Dooley SW, Jarvis WS, Martone WJ, Snider DE. Multidrug-resistant tuberculosis (éditorial). Ann Intern Med 1992 ; 117 : 257-8.
4. Villarino ME, Geiter LJ, Simone PM. The multidrug-resistant tuberculosis challenge to public health efforts to control tuberculosis. Center for Disease Control, Atlanta. Publ Health Rep 1992 ; 107 : 616-25.
5. OMS. Lutte contre la tuberculose dans la Région européenne de l'OMS. Aide-mémoire 07/02, Copenhague, 17 septembre 2002.
6. Bouvet E. Quels sont les problèmes posés par la tuberculose en France en 2003 ? Med Sci (Paris) 2003 : 19 : 1146-51.
7. OMS. Tuberculose. Centre des médias. Infection et transmission. Aide-mémoire no 104, révisé en mars 2006.
8. Han LL, Sloutsky A, Canales R, et al. Acquisition of drug resistance in multidrug resistant Mycobacterium tuberculosis during directly observed empiric retreatment with standardized regimens. Int J Tuberc Lung Dis 2005 ; 9 : 818-21.
9. Bishop KS, Blumberg L, Trollip AP, et al. Characterisation of the pncA gene in Mycobacterium isolates from Gauteng, South Africa. Int J Tuberc Lung Dis 2001 ; 5 : 952-7.
10. European concerted action on new generation genetic markers and techniques for the epidemiology and control of tuberculosis. Emerg Infect Dis 2006 ; 12 : 736-43.
11. Hunsiff SS, Nivin B, Sacajiu G, et al. Persistence of a highly resistant strain of tuberculosis in New York City during 1990-1999. J Infect Dis 2003 ; 188 : 356-63.
12. Tsolaki AG, Gagneux S, Pym AS, et al. Genomic deletions classify Beijing/W strains as a distinct genetic lineage of Mycobacterium tuberculosis. J Clin Microbiol 2005 ; 43 : 3185-91.
13. Beijing genotype of Mycobacterium tuberculosis is significantly associated with human immunodeficiency virus infection and multidrug resistance in cases of tuberculous meningitis. J Clin Microbiol 2006 ; 44 : 3934-9.
14. MMWR (CDC). Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs : worldwide, 2000-2004. Weekly 2006 ; 55 : 301-5.
15. Masjedi MR, Farnia P, Sorooch S, et al. Extensively drug-resistant tuberculosis : 2 years of surveillance in Iran. Clin Infect Dis 2006 ; 43 : 841-7.
16. Dahle UR. Extensively drug resistant tuberculosis. Beware patients lost in follow-up. Br Med J 2006 ; 333 : 7570-5.
17. Hannan MM, Peres H, Maltez F, et al. Investigation and control of a large outbreak of multi-drug resistant tuberculosis at a central Lisbon hospital. J Hosp Infect 2001 ; 47 : 91-7.
18. Campos PE, Suarez PG, Sanchez J, et al. Multi-drug resistant tuberculosis in HIV-infected persons, Peru. Emerg Infect Dis 2002 ; 9 : 1571-8.
19. th international AIDS conference, 13-18 August 2006. Toronto, Canada : International Aids Society, 2006 (abstract THLB0210.)
20. Ghandi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006 ; 368 : 1575-80.
21. Deadly TB found in all nine provinces of SA. Business Day (Johannesburg) 18 octobre 2006.
22. Jenkins R. Case of extremely drug resistant TB confirmed in Johannesburg. Health News 14 septembre 2006.
23. MMWR (CDC). Notice to readers: revised definition of extensively drug-resistant tuberculosis. Weekly 2006 ; 55 : 1176.
24. th Union World Conference on Lung Health, 31 octobre 2006. Extensively drug-resistant TB (XDR) Summary report by Castro KG, for the first global XDR TB task force. 9-10 octobre 2006, Geneva, Switzerland. Atlanta : Center for Disease control and prevention. US Department of health and human services.
25. Hopewell PC, Pal M, Maher D, et al. International standards for tuberculosis care. Lancet Infect Dis 2006 ; 6 : 710-25.
26. The tuberculosis X factor. Lancet Infect Dis 2006 ; 6 : 679.